渭南市医保门诊慢特病鉴定标准_渭南政能量_荣耀渭南网

荣耀小政 发表于 2025-11-26 09:53

渭南市医保门诊慢特病鉴定标准

<div class="wx_rich_media_content" id="jsWxContainer"><p style="text-align: center; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; vertical-align: baseline; font-size: 37pt; font-family: 宋体;" 宋体';mso-bidi-font-family:="" 宋体;color:="" #000000;mso-fareast-language:="" en-us;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 7.15pt;margin-right:="" 70.1pt;text-align:="" center;line-height:="" 101%;'=""><p style="mso-margin-top-alt: auto;mso-margin-bottom-alt: auto;mso-bidi-font-size: 10.5pt;margin-bottom: 0.0pt;margin-left: 0.0pt;text-indent: 0.0pt;mso-pagination: widow-orphan;layout-grid-mode: char;mso-layout-grid-align: none;text-autospace: none;mso-line-break-override: restrictions;vertical-align: baseline;font-size: 37.0pt;font-family: 宋体;mso-fareast-font-family: " 宋体';mso-bidi-font-family:="" 宋体;color:="" #000000;mso-fareast-language:="" en-us;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 7.15pt;margin-right:="" 70.1pt;text-align:="" center;line-height:="" 101%;'=""> <p style="margin-left: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 5.0pt;text-indent:="" 28.8pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;line-height:="" 93%;mso-outline-level:="" 3;'="">一、高血压<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">经二级及以上医疗机构临床诊断明确，并具备下列并发症之一者：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.脑血管病意外(包括有相关症状的脑梗死、短暂性脑缺血发作、脑出血、蛛网膜下腔出血)或高血压脑病；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.高血压性心脏疾病(心功能Ⅲ级及以上、冠心病、稳定性心绞痛、不稳定性心绞痛、心肌梗死);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.高血压肾病，具备以下之一：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(1)尿常规检查中，不同时间点至少两次尿蛋白++(排除泌尿系感染);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(2)尿蛋白定量>300mg/24 小时或尿白蛋白/肌酐比> 300mg/g(排除泌尿系感染);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(3)估算肾小球滤过率eGFR<60m1/(min ·1.73m)或血肌酐 Scr≥177μmol/L;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(4)肾组织活检诊断为高血压肾病。<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.眼底出血，渗出或视乳头水肿；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">5.主动脉夹层。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.1pt;margin-left:="" 33.95pt;line-height:="" 93%;mso-outline-level:="" 3;'="">二、糖尿病<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.25pt;margin-left:="" 40.5pt;line-height:="" 93%;mso-outline-level:="" 3;'="">(一)1型糖尿病<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.25pt;margin-left:="" 40.5pt;line-height:="" 93%;mso-outline-level:="" 3;'="">经二级及以上医疗机构临床确诊1型糖尿病，可不伴并发症。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 12.0pt;margin-left:="" 39.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">(二)2型和其他型糖尿病伴并发症<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">经二级及以上医疗机构临床确诊2型糖尿病和其他型糖尿病，且至少具备心、脑、肾、眼、周围神经、周围血管等并发症之一：<p style="margin-left: 0pt; line-height: normal; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.糖尿病合并心脏损害，具备以下之一：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">心功能Ⅲ级及以上、冠心病、稳定性心绞痛、不稳定性心绞痛、心肌梗死。<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.糖尿病合并脑损害，具备以下之一：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">脑梗死、脑出血、脑软化灶、单侧肌力四级及以下、偏身或肢体感觉障碍、语言障碍或吞咽功能障碍、认知功能损害、共济失调。<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.糖尿病肾病，具备以下之一：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(1)尿常规检查中，不同时间点至少两次尿蛋白++(排除泌尿系感染);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(2)尿蛋白定量>300mg/24 小时或尿白蛋白/肌酐比> 300mg/g(排除泌尿系感染);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(3)估算肾小球滤过率eGFR<60m1/(min ·1.73m2)或血肌酐 Scr≥177μmol/L;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(4)肾组织活检诊断为糖尿病肾病。<o:page></o:page><p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.糖尿病视网膜病变<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">5.糖尿病周围神经病变<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">肌电图或感应阈值检查阳性。<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">糖尿病周围血管病变，具备以下之一：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(1)下肢血管彩超提示有斑块形成；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(2)下肢动脉血管狭窄或闭塞，或伴有下肢皮肤溃疡；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(3)肢端皮肤开放性病灶达到肢端坏疽的程度。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.55pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三、恶性肿瘤门诊治疗<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.经二级及以上医疗机构住院确诊恶性肿瘤，病理检查结果或影像学、临床实验室检查结果支持恶性肿瘤的诊断；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.需要在门诊进行放疗、化疗为主要方式的治疗，或使用化疗药品进行膀胱灌注治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.95pt;margin-left:="" 31.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">四、恶性肿瘤康复治疗<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.经二级及以上医疗机构住院确诊恶性肿瘤，病理检查结果或影像学、临床实验室检查结果支持恶性肿瘤的诊断；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.经过手术、放疗、化疗等规范化治疗或未接受手术、放疗、化疗，患者进入后续治疗阶段。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.8pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">五、器官移植抗排异治疗<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">既往有严重脏器疾病史，经二级及以上医疗机构住院手术移植异体器官(组织),移植后需长期抗排异治疗的。根据移植器官(组织)不同，分为心、肝、肺、肾、骨髓、小肠、胰腺、胰岛、造血干细胞等移植术后的抗排异治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 1.1pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">六、脑血管病后遗症(脑卒中后遗症)<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.经二级及以上医疗机构明确诊断为脑梗死、脑栓塞、脑出血、蛛网膜下腔出血，影像学检查结果阳性；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.治疗3个月后还有明显未恢复的神经症状，包括单个肢体肌力三级及以下、感觉障碍、颅神经障碍、失语、认知功能障碍、共济失调等，经确诊为脑卒中后遗症，仍需继续治疗。<p style="margin-bottom: 0pt; margin-left: 0pt; vertical-align: baseline; font-size: 37pt; font-family: 宋体;" 宋体';mso-bidi-font-family:="" 宋体;color:="" #000000;mso-fareast-language:="" en-us;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.55pt;text-indent:="" 30.95pt;line-height:="" 130%;'="">七、肺结核活动期<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.经二级及以上医疗机构临床诊断明确，具有肺结核常见临床表现；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.胸部影像学检查符合结核病改变；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.痰结核菌检查或结核菌素试验阳性。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 31.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">八、耐药性结核病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.经二级及以上医疗机构临床诊断明确，符合结核病(包括肺结核)临床表现；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.结核病相关实验室检查阳性；<o:page></o:page><p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.有相应部位结核病的影像学特征；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.药敏试验证实对一种或多种一线二线结核药物具有耐药性。<p style="vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 11.65pt;margin-right:="" 3.55pt;margin-left:="" 0.2pt;text-indent:="" 30.95pt;line-height:="" 139%;'="">九、精神疾病(包括精神分裂症、双相障碍、妄想性障碍、分裂情感性障碍、癫痫性精神病、重度以上精神发育迟滞)<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.在精神病专科医院或二级及以上综合医院精神卫生科确诊为精神分裂症、双相障碍、妄想性障碍、分裂情感性障碍、癫痫性精神病、重度以上精神发育迟滞；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.相关精神疾病检测量表或相关辅助检查结果支持诊断。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.1pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">十、透析(含血液透析、腹膜透析)<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">经二级及以上医疗机构住院诊断有急、慢性肾功能衰竭或其它基础疾病需要长期透析治疗的，并符合以下实验室诊断之一：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.估算肾小球滤过率eGFR<15m1/(min ·1.73m), 或血肌酐Scr≥707μmo1/L 且经临床认定需长期透析治疗；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.60岁以上和糖尿病肾衰患者估算肾小球滤过率 eGFR<15m1/(min·1.73m), 或血肌酐>528μmol/L且经临床认定需长期透析治疗；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.707μmol/L≥ 血肌酐≥528μmol/L 的慢性肾病患者，出现了难以纠正的电解质酸碱代谢紊乱或容量负荷过重、心力衰竭、代谢性脑病、蛋白质能量消耗等症状和体征需要长期透析治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-left:="" 31.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">十一、氟骨病<p style="mso-margin-top-alt: auto;mso-margin-bottom-alt: auto;txt-align: left;margin-left: 0.0pt;line-height: normal;mso-pagination: widow-orphan;layout-grid-mode: char;mso-layout-grid-align: none;text-autospace: none;mso-line-break-override: restrictions;vertical-align: baseline;font-size: 12.0pt;mso-bidi-font-size: 10.5pt;font-family: Arial;mso-fareast-font-family: " arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.出生并居住在地方性氟中毒病区或出生后迁居病区1年以上，颈、腰和四肢大关节疼痛，肢体运动功能障碍以及骨和关节 X 线征象异常，经二级及以上医疗机构诊断为中、重度的氟骨症病例；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.影像学 (X 线检查、CT、核磁等)检查有氟骨病表现。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 11.7pt;margin-left:="" 31.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">十二、大骨节病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.具有病区接触史(6个月以上),有多发性、对称性手指关节增粗或短指(趾)畸形等体征并排除其他相关疾病，经二级及以上医疗机构临床诊断为大骨节病Ⅱ度及以上的病例；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2. 手部或踝关节侧位X线片具有大骨节病X线征象。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.9pt;margin-left:="" 31.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">十三、克山病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.在克山病病区连续生活6个月以上，具有心肌病或心功能不全的临床表现，排除其他疾病，经二级及以上医疗机构临床诊断克山病；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.心功能Ⅱ级及以上者。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">十四、儿童苯丙酮尿症<o:page></o:page><p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.三级医院或专科医院按照临床诊疗规范确诊为普通型苯丙酮尿症或四氢生物蝶呤缺乏症；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2. 血 Phe>120umo1/L(2mg/d1),Phe/Tyr>2.0; 或基因检测发现两个PAH 等位基因均存在致病变异。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 31.7pt;line-height:="" 93%;mso-outline-level:="" 3;'="">十五、甲状腺功能异常<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.9pt;margin-left:="" 38.2pt;line-height:="" 95%;mso-outline-level:="" 3;'="">(一)甲状腺功能亢进<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，具备甲状腺功能亢进临床表现；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.甲状腺功能化验指标异常：血清 TT3 或( 和 )TT4 升高，TSH 降低；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.B 超检查甲状腺肿大。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 11.05pt;margin-left:="" 37.7pt;line-height:="" 95%;mso-outline-level:="" 3;'="">(二)甲状腺功能减退<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，具备甲状腺功能减退临床表现；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.甲状腺功能化验指标异常：血清TT4、FT4 降低，TSH 升高；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.需长期替代药物治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.35pt;margin-left:="" 31.7pt;line-height:="" 93%;mso-outline-level:="" 3;'="">十六、血友病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构临床诊断明确，具备1、2、3条或1、2、 4 条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.有关节、肌肉、深部组织出血，活动过久、用力、创伤或手术后异常出血史；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.实验室检查结果阳性；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.有明确(活动性)出血症状：如关节、肌肉、深部组织出血等或实验室检查结果为VI因子活性检测<25%、IX因子活性检查<25%;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.有严重并发症：如关节畸形、假性肿瘤等。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.8pt;margin-left:="" 31.65pt;line-height:="" 92%;mso-outline-level:="" 3;'="">十七、再生障碍性贫血<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.全血细胞(包括网织红细胞)减少，淋巴细胞比例增高。至少符合以下三项中两项： HGB<100g/L;PLT<50×109/L; 中性粒细胞绝对值(ANC)<1.5×109/L;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.骨髓活检和多部位穿刺检查：增生减低或重度减低，造血组织减少，非造血细胞比例增高；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.排除引起全血细胞减少的其他疾病。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.95pt;margin-left:="" 31.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">十八、癫痫<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.常规脑电图或诱发试验脑电图可见癫痫波形，棘波、尖波、慢波或棘慢波综合；<o:page></o:page><p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.抗癫痫药物尚在治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.3pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">十九、脑瘫<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.中枢性运动障碍持续存在，运动和姿势发育异常，反射发育异常，肌张力及肌力异常；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.需长期门诊康复治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.4pt;margin-left:="" 31.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">二十、慢性阻塞性肺疾病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构确诊慢性阻塞性肺疾病，符合1、2、3 条或1、4条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.有慢性咳嗽、咳痰、喘息、呼吸困难等临床表现；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.胸部影像学表现为双肺纹理增粗、紊乱，肺气肿表现；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3. 吸入支气管舒张剂后FEV1/FVC<70%,或多发肺大泡不宜肺功能检查，提供胸部 CT有肺大泡报告单；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.合并呼吸衰竭。<p style="margin-bottom: 0pt; text-indent: 0pt; vertical-align: baseline; font-size: 37pt; font-family: 宋体;" 宋体';mso-bidi-font-family:="" 宋体;color:="" #000000;mso-fareast-language:="" en-us;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.7pt;margin-left:="" 30.95pt;line-height:="" 92%;'="">二十一、支气管哮喘<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构临床诊断明确，符合1-4条或4、5条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.反复发作性喘息、气急、胸闷或咳嗽，多与接触变应原、冷空气、物理、化学性刺激、病毒性上呼吸道感染、运动等有关；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.发作时在双肺可闻及散在或弥漫性、以呼气相为主的哮鸣音，呼气相延长<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.上述症状可经治疗缓解或自行缓解；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.除外其他疾病所引起的喘息、气急、胸闷和咳嗽；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">5.临床表现不典型者(如无明显喘息或体征)应有下列三项中至少一项阳性：(1)支气管激发试验或运动试验阳性；(2) 支气管舒张试验阳性；(3)昼夜PEF 变异率≥20%。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.05pt;margin-left:="" 30.7pt;line-height:="" 92%;mso-outline-level:="" 3;'="">二十二、特发性肺间质纤维化<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构临床诊断明确，具备1、2条或3条或1、4条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.CT 检查：典型表现胸膜下基底部分布为主的网格改变，蜂窝改变伴或不伴牵拉性支气管扩张；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.肺功能检查限制性通气功能障碍、弥散量降低；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.肺组织活检病理学依据；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.合并呼吸衰竭。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 30.7pt;line-height:="" 93%;mso-outline-level:="" 3;'="">二十三、冠心病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.冠状动脉造影或其它影像学检查提示有>50%狭窄；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.至少具备以下其中一项：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(1)有心功能Ⅲ级以上的住院病历资料，心电图和超声心动图检查证实左心室扩大；<o:page></o:page><p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(2)有心肌梗塞病史，住院治疗后好转且出院后需连续门诊治疗；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(3)除外药物性和一过性心律失常，有下列严重心律失常之一需药物控制的：①动态心电图提示清醒静息状态下，持续窦性心动过缓≤40次/分；②Ⅱ度Ⅱ型以上窦房阻滞；③持续性房扑或持续性房颤；④Ⅱ度Ⅱ型以上房室传导阻滞或频发多源性室性早搏；⑤持续性室性心动过速；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(4)不稳定型心绞痛者近半年内反复发作，并有心电图异常；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(5)经皮球囊冠状动脉腔内成形术后、支架植入术后、旁路移植(搭桥)术后、心脏起搏器术后。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.3pt;margin-left:="" 32.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">二十四、肺源性心脏病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合1、2条或1、2、3条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，有慢性肺胸疾病或肺血管病史；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.胸片、心电图、超声心动图等检查提示肺动脉高压、右心室增大；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.有右心功能不全的临床表现。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.3pt;margin-left:="" 32.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">二十五、慢性心力衰竭<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合1、2条或1、3条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，有心力衰竭的病史、临床症状及体征<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.超声心动图：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(1)左心室舒张末内径(女性LVEDd>5.0cm 或男性LVEDd>5.5cm);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">(2)左心室射血分数LVEF≤40%;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">（3）NT-pro BNP或 BNP 符合心力衰竭诊断标准。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.65pt;margin-left:="" 30.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">二十六、心脏瓣膜病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 14.0pt;mso-char-indent-count:="" 1.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构临床诊断心脏瓣膜病或风湿性心脏病，并符合以下任意一条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.超声心动图显示中重度瓣膜病变；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.心脏瓣膜置换术后合并心力衰竭。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.5pt;margin-left:="" 30.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">二十七、心肌病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合1条或2条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.扩张性心肌病：二级及以上医疗机构临床诊断明确；左心室舒张末内径(LVEDd)>5.0cm (女性)和 LVEDd>5.5cm(男性 ) (或大于年龄和体表面积预测值的117%,即预测值的2倍SD+5%),左心室射血分数LVEF<45%(Simpsons法);发病时除外高血压、心脏瓣膜病、先天性心脏病或缺血性心脏病。<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.肥厚性心肌病：二级及以上医疗机构临床诊断明确；左心室舒张末任意节段室壁厚度≥15mm,且无其他已知的可引起心肌肥厚的病因，或患者室壁厚度为13-14mm,同时伴有肥厚性心肌病家族史或有基因检测阳性结果。<o:page></o:page><p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.1pt;margin-left:="" 30.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">二十八、病毒性肝炎<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合以下1-3条，或仅符合第4条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，且病程超过6个月；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.肝炎病毒标志物检测阳性；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.至少具备以下其中一项：(1)ALT 高于正常检测值；(2) ALT正常，但年龄大于30岁，经无创肝纤维化诊断技术检查或肝组织学检查，存在明显肝脏炎症或纤维化，肝脏硬度值LSM>7.3kPa;(3) 存在HBV或 HCV 相关肝外损害(肾小球肾炎、血管炎、结节性多动脉炎、周围神经病变等);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.肝活检有慢性中(重)度病毒性肝炎的病理改变。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.4pt;margin-left:="" 29.95pt;line-height:="" 93%;'="">二十九、肝硬化失代偿期<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合以下1、2、3条，或符合1、4条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，有慢性肝病史；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.有门静脉高压的临床症状、体征及检查(实验室或影像检查);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3. 实验室检查：血清白蛋白<35g/L,胆红素>35μmo1/L, 凝血酶原活动度<60%;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.出现以下并发症之一：消化道出血、腹水、脾功能亢进及脾大、自发性腹膜炎、肝性脑病、肝肾综合征、肝肺综合症等。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.7pt;margin-left:="" 30.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">三十、慢性肾功能不全失代偿期<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确，有慢性肾脏疾病史；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2. 肾功能检查：血肌酐>177μmol/L和(或)肌酐清除率<60m1/min。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 30.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三十一、肾病综合征<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2. 实验室检查：(1)大量蛋白尿(尿蛋白定量>3.5g/24h), (2)低蛋白血症(血浆白蛋白<30g/L);<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 11.6pt;margin-left:="" 30.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">三十二、慢性肾小球肾炎<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.检测尿蛋白≥1.0g/24h 及尿蛋白≥++,两次以上；持续血尿：尿红细胞≥5个或红细胞计数>10000个/m1;<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.三个月以上病史或肾活检病理报告。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 5.0pt;margin-left:="" 29.7pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三十三、免疫性血小板减少症<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.血常规：血小板计数减少(至少2次以上);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.骨髓检查巨核细胞数增多或正常，有成熟障碍。<o:page></o:page><p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.95pt;margin-left:="" 30.7pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三十四、儿童生长激素缺乏症<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.临床表现：(1)匀称性身材矮小：身高落后于同年龄、同性别正常健康儿童身高的第3百分位数(-1.88SD)或2个标准差 (-2SD)以下；(2)生长缓慢：速率<7cm/年(3岁以下),<5cm/年 (3岁-青春期前),<6cm/年(青春期);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.骨龄检查较实际年龄落后2年以上；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.GH 激发试验显示GH 峰值<10μg/L; 血清胰岛素样生长因子 1 (IGF-1) 水平低于正常。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 12.55pt;margin-left:="" 34.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三十五、强直性脊柱炎<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.符合以下任意一条：(1)下腰背痛持续至少3个月，疼痛随活动改善，但休息不减轻；(2)腰椎在前后和侧屈方向活动受限；(3)胸廓活动度小于同年龄和性别的正常参考值；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.影像学检查：双侧骶髂关节炎Ⅱ-IV级，或单侧骶骼关节炎 Ⅲ-IV 级。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 11.5pt;margin-left:="" 30.7pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三十六、类风湿性关节炎<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.符合1987年美国风湿病学会(ACR)类风湿性关节炎分类标准或2010年ACR/EULAR 类风湿性关节分类标准。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 4.85pt;margin-left:="" 29.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">三十七、慢性骨髓炎<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.X 线及其他影像学检查、实验室检查阳性报告。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 29.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">三十八、帕金森病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.有运动迟缓、静止性震颤、肌强直等临床表现。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.55pt;margin-left:="" 29.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">三十九、系统性红斑狼疮<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级及以上医疗机构临床诊断明确；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.符合美国风湿病学(ACR)诊断标准，并有一个或一个以上脏器损害的中、重度病人(含血液系统损害)。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.75pt;margin-left:="" 29.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">四十、银屑病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合1、2条或1、3条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.二级甲等及以上医疗机构临床诊断明确，慢性反复发作，有一年以上的治疗记录；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2. 寻常型银屑病 BSA≥10%或 PASI>10分的中重度患者；<o:page></o:page><p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.关节病型(除外风湿相关关节损害)、脓疱型或红皮病型银屑病。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 9.2pt;margin-left:="" 29.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">四十一、中枢神经系统脱髓鞘疾病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">包括多发性硬化、视神经脊髓炎谱系疾病。经公立三级医疗机构住院确诊，需长期使用激素、免疫抑制剂、生物制剂治疗。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 0.35pt;margin-left:="" 29.2pt;line-height:="" 93%;mso-outline-level:="" 3;'="">四十二、运动神经元病<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">符合1-5条或符合6条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.临床、电生理或病理检查显示下运动神经元病变的证据；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.临床检查显示上运动神经元病变的证据；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.经三级医疗机构确诊，相关检查支持；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">4.排除其他可导致上下神经元病变的疾病；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">5.患者存在一定程度的生活能力或工作能力的下降(经日常生活能力评定量表评定);<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">6.三级医疗机构临床明确诊断为下列疾病之一：运动神经元病；肌萎缩侧索硬化；进行性肌萎缩；进行性延髓麻痹；原发性侧索硬化。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.2pt;margin-left:="" 32.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">四十三、股骨头坏死<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构临床诊断明确，同时具备以下任意一条：<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.CT:出现骨硬化带包绕坏死骨、修复骨，或软骨下骨断裂；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.MRI:T1加权像局限性软骨下带状(也称线状)低信号影或T2加权像双线征；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.放射性核素检查显示股骨头坏死。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 10.55pt;margin-left:="" 32.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">四十四、系统性硬化症<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">二级及以上医疗机构临床诊断明确，符合2013年ACR/EULAR 制定的 SSc 分类标准。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 0.05pt;margin-left:="" 32.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">四十五、肝豆状核变性<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">三级医疗机构临床诊断明确，同时具备以下任意一条：1.血清铜蓝蛋白、24小时尿铜异常，角膜K-F 环有可能阳性；2.ATP 7B基因检测异常；3.肝组织铜含量增高。<p style="text-indent: 0pt; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;margin-top:="" 0.05pt;margin-left:="" 32.2pt;line-height:="" 92%;mso-outline-level:="" 3;'="">四十六、重症肌无力<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">1.波动性骨骼肌无力，活动后加重、休息后减轻；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">2.新斯的明实验阳性，或肌电图重复电刺激波幅递减；<p style="margin-left: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;text-indent:="" 28.0pt;mso-char-indent-count:="" 2.0;mso-char-indent-size:="" 14.0;'="">3.经二级甲等及以上医院神经内科医生诊断的住院患者。<p style="margin-left: 0pt; text-indent: 0pt; line-height: normal; vertical-align: baseline; font-size: 12pt; font-family: Arial;" arial';color:="" #000000;layout-grid-mode:="" line;font-weight:="" normal;mso-bidi-font-weight:="" normal;'=""><o:p> </o:p><o:page></o:page><mp-style-type data-value="3"></mp-style-type></div>

赵建国 发表于 2025-11-26 14:05

老百姓记不住这些，平时也不太想去了解，生病了才去了解这些东西

@不倒翁 发表于 2025-11-26 15:29

谢谢分享一下

@不倒翁 发表于 2025-11-26 15:30

赵建国发表于 2025-11-26 14:05
老百姓记不住这些，平时也不太想去了解，生病了才去了解这些东西

对，莫人愿意记这些！！

紫缘归梦 发表于 2025-11-26 17:23

有需要的了解一下。

夕阳多美好 发表于 2025-11-26 17:38

需要的仔细看看。

劲舞骄阳 发表于 2025-11-26 22:37

这个可以学习一下

好人张 发表于 2025-11-26 23:06

谢谢你的分享。

口天花 发表于 2025-11-26 23:33

谢谢你知道了。

方圆百里 发表于 2025-12-1 08:59

三马路慢性病的鉴定标准

页: [1]

荣耀渭南网's Archiver

渭南市医保门诊慢特病鉴定标准